WithdrawnNot Applicable

Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry

Stopped: The study was withdrawn by the sponsor

0Started 2023-04-01

Plain-language summary

Patient Registry aiming to provide regional evidence documenting the clinical merit of EUS (Endoscopic\_ Ultrasound) guided liver biopsy, per local standard of practice, in patients with suspected liver disease indicated for an endoscopic intervention and a liver biopsy.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult (per local age threshold) * Suspected liver disease based on abnormal liver function tests, standard ultrasound, transient elastography (Fibro Scan) or CT or MRI of the liver * Planned upper endoscopy to evaluate for varices * Planned liver biopsy based on suspected hepatitis or cirrhosis Exclusion Criteria: * Severe Coagulation/bleeding disorder as defined by INR \> 2 IU which cannot be corrected with FFP or Platelets \< 50,000 per microliter which cannot be corrected with platelet transfusion. * Severe organ failure considered unsafe to undergo sedation (ASA class 4 or 5) * Inability to provide informed consent

What they're measuring

Number of endoscopic, endosonographic, and radiologic interventions undergone to reach a diagnostic liver biopsy [Phase 1]

Timeframe: 30 Days in Phase 1

Number of endoscopic, endosonographic, and radiologic interventions undergone to reach a diagnostic liver biopsy [Phase 2]

Timeframe: 12 months in phase 2

Trial details

NCT IDNCT05817994

SponsorSheikh Shakhbout Medical City

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-01

View on ClinicalTrials.gov More Liver Diseases trials